Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus

被引：0
作者：
Gordana Dragovic
Colette Smith
Djordje Jevtovic
Mike Youle
David Back
机构：
[1] University of Belgrade,Institute of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine
[2] Royal Free and University College Medical School,Department of Primary Care and Population Sciences
[3] University of Belgrade,Institute of Infective and Tropical Disease “Dr Kosta Todorovic”, School of Medicine
[4] Royal Free and University College Medical School,Royal Free Centre for HIV Medicine
[5] University College London,Department of Pharmacology and Therapeutics
[6] University of Liverpool,undefined
来源：
BMC Infectious Diseases | / 14卷 / Suppl 4期
关键词：
Liver Fibrosis; Nevirapine; Fibrosis Stage; Liver Fibrosis Stage; Nevirapine Plasma;
D O I：
10.1186/1471-2334-14-S4-O17
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis
    Pineda, Juan A.
    Neukam, Karin
    Mallolas, Josep
    Lopez-Cortes, Luis F.
    Carton, Jose A.
    Domingo, Pere
    Moreno, Santiago
    Iribarren, Jose A.
    Clotet, Bonaventura
    Crespo, Manuel
    de Los Santos, Ignacio
    Ortega, Enrique
    Knobel, Hernando
    Jimenez-Exposito, Maria J.
    Macias, Juan
    JOURNAL OF INFECTION, 2012, 64 (02) : 204 - 211
  • [22] Stage of liver fibrosis in patients with congenital bleeding disorders and hepatitis C virus infection
    Kucharska, Marta
    Zaleska-Dorobisz, Urszula
    Szymczak, Aleksandra
    Inglot, Marcin
    Rymer, Weronika
    Zalewska, Malgorzata
    Malyszczak, Krzysztof
    Kuliszkiewicz-Janus, Malgorzata
    Inglot, Malgorzata
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (06): : 412 - 417
  • [23] Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus
    Reid, Michael
    Ma, Yifei
    Scherzer, Rebecca
    Price, Jennifer C.
    French, Audrey L.
    Huhn, Gregory D.
    Plankey, Michael W.
    Peters, Marion
    Grunfeld, Carl
    Tien, Phyllis C.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (08) : 1289 - 1297
  • [24] Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
    A. Rivero-Juarez
    A. Gutierrez-Valencia
    M. Castaño
    D. Merino
    K. Neukam
    M. J. Ríos-Villegas
    M. A. Lopez-Ruz
    P. Jiménez-Aguilar
    M. Marquez
    A. Collado
    A. Gomez-Vidal
    J. Hernandez-Quero
    F. Tellez
    E. Fernandez-Fuertes
    A. Rivero
    L. F. López-Cortés
    European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34 : 2247 - 2255
  • [25] High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease
    Merchante, Nicolas
    Parra-Sanchez, Manuel
    Rivero-Juarez, Antonio
    Cifuentes, Celia
    Camacho, Angela
    Macias, Juan
    Martinez-Duenas, Loreto
    Perez-Navarro, Elisabet
    Rivero, Antonio
    Pineda, Juan A.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (08): : 532 - 535
  • [26] Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co-infected patients
    Tural, C
    Fuster, D
    Tor, J
    Ojanguren, I
    Sirera, G
    Ballesteros, A
    Lasanta, JAJ
    Planas, R
    Rey-Joly, C
    Clotet, B
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (02) : 118 - 125
  • [27] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Eric Dailly
    Olivier Tribut
    Pierre Tattevin
    Cédric Arvieux
    Philippe Perré
    François Raffi
    Pascale Jolliet
    European Journal of Clinical Pharmacology, 2006, 62 : 523 - 526
  • [28] Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients
    Dailly, Eric
    Tribut, Olivier
    Tattevin, Pierre
    Arvieux, Cedric
    Perre, Philippe
    Raffi, Francois
    Jolliet, Pascale
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (07) : 523 - 526
  • [29] Value of serum fibronectin for assessment of liver fibrosis in chronic hepatitis C virus patients
    Ahmed A. Ghafar
    Elsayed Ghoneem
    Ramy H. Agwa
    Ahmed Akef
    Ahmad S. H. Hasan
    Nahed Abdallah
    The Egyptian Journal of Internal Medicine, 2019, 31 (4) : 465 - 472
  • [30] Telaprevir in the Treatment of Acute Hepatitis C Virus Infection in HIV-Infected Men
    Fierer, Daniel S.
    Dieterich, Douglas T.
    Mullen, Michael P.
    Branch, Andrea D.
    Uriel, Alison J.
    Carriero, Damaris C.
    van Seggelen, Wouter O.
    Hijdra, Rosanne M.
    Cassagnol, David G.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (06) : 873 - 879
12345